SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-033630
Filing Date
2024-07-31
Accepted
2024-07-31 07:50:41
Documents
89
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lnth-20240630.htm   iXBRL 10-Q 1378614
2 EX-10.2 lnth10q-063024ex102.htm EX-10.2 61788
3 EX-31.1 lnth10q-063024ex311.htm EX-31.1 11666
4 EX-31.2 lnth10q-063024ex312.htm EX-31.2 11569
5 EX-32.1 lnth10q-063024ex321.htm EX-32.1 9741
  Complete submission text file 0001628280-24-033630.txt   7846898

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20240630.xsd EX-101.SCH 54643
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20240630_cal.xml EX-101.CAL 89127
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20240630_def.xml EX-101.DEF 219277
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20240630_lab.xml EX-101.LAB 690472
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20240630_pre.xml EX-101.PRE 470125
92 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20240630_htm.xml XML 1115747
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 241159919
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)